Different mechanisms of vaccine-induced and infection-induced immunity to Bordetella bronchiseptica

Microbes and Infection

Volumn 9, Issue 4, 2007, Pages 442-448

  Gopinathan, Lakshmi ^b   Kirimanjeswara, Girish S ^a   Wolfe, Daniel N ^a   Kelley, Monica L ^a   Harvill, Eric T ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Bordetella; Immunity; Vaccine

Indexed keywords

COMPLEMENT; FC RECEPTOR; PERTUSSIS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; BORDETELLA BRONCHISEPTICA; C57BL 6 MOUSE; COMPLEMENT SYSTEM; CONTROLLED STUDY; DISEASE MODEL; HOST RESISTANCE; IMMUNOMODULATION; INFECTION PREVENTION; INFECTION RESISTANCE; MOUSE; NONHUMAN; PERTUSSIS; PRIORITY JOURNAL; SERUM; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; B-LYMPHOCYTES; BACTERIAL VACCINES; BORDETELLA BRONCHISEPTICA; BORDETELLA INFECTIONS; COMPLEMENT SYSTEM PROTEINS; MICE; MICE, INBRED C57BL; RECEPTORS, IGG; RESPIRATORY SYSTEM; RESPIRATORY TRACT INFECTIONS;

ANIMALIA; BORDETELLA; BORDETELLA BRONCHISEPTICA; MURINAE;

EID: 33947204954     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2007.01.001     Document Type: Article

References (30)

1. van der Zee A., Mooi F., Van Embden J., and Musser J. Molecular evolution and host adaptation of Bordetella spp.: phylogenetic analysis using multilocus enzyme electrophoresis and typing with three insertion sequences. J. Bacteriol. 179 (1997) 6609-6617
2. Bjornstad O.-N., and Harvill E. Evolution and emergence of Bordetella in humans. Trends Microbiol. 13 (2005) 355-359
3. Preston A. Bordetella pertussis: the intersection of genomics and pathobiology. CMAJ 173 (2005) 55-62
4. Heininger U.-P., Cotter A., Fescemyer H., Martinez de Tejada G., Yuk M., Miller J., and Harvill E. Comparative phenotypic analysis of the Bordetella parapertussis isolate chosen for genomic sequencing. Infect. Immun. 70 (2002) 3777-3784
5. Mills K.-H. Immunity to Bordetella pertussis. Microbes Infect. 3 (2001) 655-677
6. Bemis D.-A. Bordetella and Mycoplasma respiratory infections in dogs and cats, Vet. Clin. North Am. Small Anim. Pract. 22 (1992) 1173-1186
7. Goodnow R.-A. Biology of Bordetella bronchiseptica. Microbiol. Rev. 44 (1980) 722-738
8. Harvill E.-T., Cotter P., and Miller J. Pregenomic comparative analysis between Bordetella bronchiseptica RB50 and Bordetella pertussis tohama I in murine models of respiratory tract infection. Infect. Immun. 67 (1999) 6109-6118
9. Ellis J.-A., Haines D., West K., Burr J., Dayton A., Townsend H., Kanara E., Konoby C., Crichlow A., Martin K., and Headrick G. Effect of vaccination on experimental infection with Bordetella bronchiseptica in dogs. J. Am. Vet. Med. Assoc. 218 (2001) 367-375
10. Farrington D.-O., and Switzer W. Parenteral vaccination of young swine against Bordetella bronchiseptica. Am. J. Vet. Res. 40 (1979) 1347-1351
11. Riising H.-J., van Empel P., and Witvliet M. Protection of piglets against atrophic rhinitis by vaccinating the sow with a vaccine against Pasteurella multocida and Bordetella bronchiseptica. Vet. Rec. 150 (2002) 569-571
12. Matherne C.-M., Steffen E., and Wagner J. Efficacy of commercial vaccines for protecting guinea pigs against Bordetella bronchiseptica pneumonia. Lab. Anim. Sci. 37 (1987) 191-194
13. Harris D.-L., and Switzer W. Nasal and tracheal resistance of swine against reinfection by Bordetella bronchiseptica. Am. J. Vet. Res. 30 (1969) 1161-1166
14. Yoda H., Nakagawa M., Muto T., and Imaizumi K. Development of resistance to reinfection of Bordetella bronchiseptica in guinea pigs recovered from natural infection. Nippon. Juigaku Zasshi 34 (1972) 191-196
15. Kitamura D., Roes J., Kuhn R., and Rajewsky K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350 (1991) 423-426
16. Circolo A., Garnier G., Fukuda W., Wang X., Hidvegi T., Szalai A., Briles D., Volanakis J., Wetsel R., and Colten H. Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA. Immunopharmacology 42 (1999) 135-149
17. Allen A.-G., Isobe T., and Maskell D. Identification and cloning of waaF (rfaF) from Bordetella pertussis and use to generate mutants of Bordetella spp. with deep rough lipopolysaccharide. J. Bacteriol. 180 (1998) 35-40
18. Kirimanjeswara G.-S., Mann P., and Harvill E. Role of antibodies in immunity to Bordetella infections. Infect. Immun. 71 (2003) 1719-1724
19. Mills K.-H., Ryan M., Ryan E., and Mahon B.-P. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis. Infect. Immun. 66 (1998) 594-602
20. Leef M., Elkins K.-L., Barbic J., and Shahin R.-D. Protective immunity to Bordetella pertussis requires both B cells and CD4(+) T cells for key functions other than specific antibody production. J. Exp. Med. 191 (2000) 1841-1852
21. Barrington R., Zhang M., Fischer M., and Carroll M. The role of complement in inflammation and adaptive immunity. Immunol. Rev. 180 (2001) 5-15
22. Sahu A., and Lambris J. Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol. Rev. 180 (2001) 35-48
23. Ravetch J.-V., and Clynes R. Divergent roles for Fc receptors and complement in vivo. Annu. Rev. Immunol. 16 (1998) 421-432
24. Kirimanjeswara G.-S., Mann P., Pilione M., Kennett M., and Harvill E. The complex mechanism of antibody-mediated clearance of Bordetella from the Lungs Requires TLR4. J. Immunol. 175 (2005) 7504-7511
25. Pishko E.-J., Kirimanjeswara G., Pilione M., and Gopinathan L. Antibody-mediated bacterial clearance from the lower respiratory tract of mice requires complement component C3. Eur. J. Immunol. 34 (2004) 184-193
26. Hellwig S.-M., van Spriel A., Schellekens J., Mooi F., and van de Winkel J. Immunoglobulin A-mediated protection against Bordetella pertussis infection. Infect. Immun. 69 (2001) 4846-4850
27. Asahi Y., Yoshikawa T., Watanabe I., Iwasaki T., Hasegawa H., Sato Y., Shimada S., Nanno M., Matsuoka Y., Ohwaki M., Iwakura Y., Suzuki Y., Aizawa C., Sata T., Kurata T., and Tamura S. Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines. J. Immunol. 168 (2002) 2930-2938
28. Hodge L.-M., Marinaro M., Jones H., McGhee J., Kiyono H., and Simecka J. Immunoglobulin A (IgA) responses and IgE-associated inflammation along the respiratory tract after mucosal but not systemic immunization. Infect. Immun. 69 (2001) 2328-2338
29. Hodge L.-M., and Simecka J. Role of upper and lower respiratory tract immunity in resistance to Mycoplasma respiratory disease. J. Infect. Dis. 186 (2002) 290-294
30. Weir E. Resurgence of Bordetella pertussis infection. CMAJ 167 (2002) 1146